IL172751A0 - Passive immune therapy against malignant melanoma - Google Patents

Passive immune therapy against malignant melanoma

Info

Publication number
IL172751A0
IL172751A0 IL172751A IL17275105A IL172751A0 IL 172751 A0 IL172751 A0 IL 172751A0 IL 172751 A IL172751 A IL 172751A IL 17275105 A IL17275105 A IL 17275105A IL 172751 A0 IL172751 A0 IL 172751A0
Authority
IL
Israel
Prior art keywords
malignant melanoma
therapy against
immune therapy
against malignant
passive immune
Prior art date
Application number
IL172751A
Original Assignee
Biolife Science Forschungs Und
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolife Science Forschungs Und filed Critical Biolife Science Forschungs Und
Publication of IL172751A0 publication Critical patent/IL172751A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL172751A 2003-06-23 2005-12-22 Passive immune therapy against malignant melanoma IL172751A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10328121A DE10328121A1 (en) 2003-06-23 2003-06-23 Passive immunotherapy for malignant melanoma
PCT/EP2004/006519 WO2005000349A2 (en) 2003-06-23 2004-06-17 Passive immune therapy against malignant melanoma

Publications (1)

Publication Number Publication Date
IL172751A0 true IL172751A0 (en) 2006-04-10

Family

ID=33546608

Family Applications (1)

Application Number Title Priority Date Filing Date
IL172751A IL172751A0 (en) 2003-06-23 2005-12-22 Passive immune therapy against malignant melanoma

Country Status (6)

Country Link
EP (1) EP1638604A2 (en)
AU (1) AU2004251010A1 (en)
CA (1) CA2530655A1 (en)
DE (1) DE10328121A1 (en)
IL (1) IL172751A0 (en)
WO (1) WO2005000349A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200720439A (en) * 2005-03-25 2007-06-01 Glycart Biotechnology Ag Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5843926A (en) * 1981-09-08 1983-03-14 Suntory Ltd Selective carcinostatic agent
USH819H (en) * 1984-04-30 1990-09-04 The United States Of America As Represented By The Secretary Of Energy Palladium-109 labeled anti-melanoma monoclonal antibodies
JPH03501209A (en) * 1988-05-17 1991-03-22 フェロン、ソルダノ Anti-idiotype antibody against anti-human high molecular weight melanoma-associated antigen
WO1994021294A1 (en) * 1993-03-19 1994-09-29 Bigner Darell D Method of treating tumors with antibodies
SE9902989D0 (en) * 1999-08-24 1999-08-24 Active Biotech Ab Novel compounds

Also Published As

Publication number Publication date
DE10328121A1 (en) 2005-02-03
WO2005000349A2 (en) 2005-01-06
EP1638604A2 (en) 2006-03-29
CA2530655A1 (en) 2005-01-06
WO2005000349A3 (en) 2005-05-06
AU2004251010A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
IL166156A0 (en) Boroproline compound combination therapy
EP1482970A4 (en) Cancer therapy
AU158118S (en) Thermal therapy pad
AU158244S (en) Thermal therapy pad
AU158120S (en) Thermal therapy pad
EP1610408A4 (en) Passive component
EP1693032A4 (en) Inter-labium pad
EP1496923A4 (en) Cancer immunotherapy
GB0326144D0 (en) Protective garments
HK1096282A1 (en) Inter-labium pad
IL172751A0 (en) Passive immune therapy against malignant melanoma
GB0226595D0 (en) Cancer therapy determination
EP1693031A4 (en) Inter-labial pad
HK1096281A1 (en) Inter-labial pad
EP1503623A4 (en) Immune t-cell stimulation
GB0412912D0 (en) Perspiration pads
GB0304855D0 (en) Face protector
GB0313027D0 (en) Mxximus chest protector
EP1534531A4 (en) Product authentication
AU158119S (en) Thermal therapy pad
GB0303289D0 (en) Combination therapy
GB0321487D0 (en) Poochie pad
GB0301338D0 (en) Slimming coffee
GB2383538B (en) Cancer treatment
GB0211718D0 (en) Cancer cure